Nuvectis Pharma Inc.

NASDAQ: NVCT · Real-Time Price · USD
6.29
-0.14 (-2.18%)
At close: Aug 15, 2025, 12:05 PM

Nuvectis Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 149K n/a
Cost of Revenue
n/a 22.9M 19.23M 12.89M
Gross Profit
n/a -22.9M -19.09M -12.89M
Operating Income
-19.85M -22.9M -19.23M -12.89M
Interest Income
847K 637K 149K 4K
Pretax Income
-19M -22.26M -19.09M -12.89M
Net Income
-19M -22.26M -18.79M -12.89M
Selling & General & Admin
6.93M 7.52M 6.01M 3.35M
Research & Development
12.92M 15.38M 13.23M 9.54M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
19.85M 22.9M 19.23M 12.89M
Interest Expense
n/a n/a 149K n/a
Selling & Marketing Expenses
n/a 14K n/a n/a
Cost & Expenses
19.85M 22.9M 19.23M 12.89M
Income Tax Expense
n/a n/a -298K -4K
Shares Outstanding (Basic)
17.11M 15.56M 12.66M 12.72M
Shares Outstanding (Diluted)
17.11M 15.56M 12.66M 12.72M
EPS (Basic)
-1.11 -1.43 -1.48 -1.01
EPS (Diluted)
-1.11 -1.43 -1.48 -1.01
EBITDA
-19M -22.9M -19.23M -12.89M
EBIT
-19M -21.9M -19.09M -12.89M
Depreciation & Amortization
n/a -1M -1.2M -7.1M